Press Releases Biophytis S.A.

Equities

ALBPS

FR001400OLP5

Real-time Euronext Paris Other stock markets 02:46:51 13/06/2024 pm IST			5-day change	1st Jan Change
0.6629 ^EUR	+1.21%		-1.13%	-67.50%

10/06	Biophytis Files Investigational New Drug Application with US FDA for Mid-stage Obesity Drug Trial	MT
10/06	Biophytis: application filed in obesity in the USA	CF

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biophytis S A : annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens	12/06	PU
Biophytis S A : announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens	12/06	PU
Biophytis S A : announces filing of an IND application with the US FDA for its phase 2 study in obesity	10/06	PU
Biophytis S A : annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité	10/06	PU
Biophytis S A : Assemblée générale mixte du 24 juin 2024	07/06	PU
Biophytis S A : Combined General Meeting of June 24, 2024	07/06	PU
Biophytis S A : annonce le design de son étude clinique de phase 2 OBA dans l'obésité	14/05	PU
Biophytis S A : announces the design of its phase 2 OBA clinical study in obesity	14/05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer